{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:36:34Z","timestamp":1780605394465,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.mehy.2019.109501","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T02:54:02Z","timestamp":1574045642000},"page":"109501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Trazodone and mirtazapine: A possible opioid involvement in their use (at low dose) for sleep?"],"prefix":"10.1016","volume":"136","author":[{"given":"S.","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.G.","family":"Pick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.109501_b0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11136-009-9462-6","article-title":"Association of insomnia with quality of life, work productivity, and activity impairment","volume":"18","author":"Bolge","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.mehy.2019.109501_b0010","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1360-0443.1994.tb03755.x","article-title":"The treatment of benzodiazepine dependence","volume":"89","author":"Ashton","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.mehy.2019.109501_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1381612023396708","article-title":"Benzodiazepine side effects: from the bench to the clinic","volume":"8","author":"Stewart","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.mehy.2019.109501_b0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1360-0443.1996.9145499.x","article-title":"Benzodiazepines in primary health care: a survey of general practitioners prescribing patterns","volume":"91","author":"Boixet","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.mehy.2019.109501_b0025","first-page":"213","article-title":"Use of prescription and nonprescription hypnotics in a Canadian elderly population","volume":"8","author":"Busto","year":"2001","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13181-013-0294-y","article-title":"In the Zzz zone: the effects of Z-drugs on human performance and driving","volume":"9","author":"Gunja","year":"2013","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.mehy.2019.109501_b0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1098-3597(03)90032-9","article-title":"Pharmacologic approaches for the treatment of chronic insomnia","volume":"5","author":"Neubauer","year":"2003","journal-title":"Clin Cornerstone"},{"issue":"8","key":"10.1016\/j.mehy.2019.109501_b0040","first-page":"7","article-title":"New clinical drug evaluation unit meeting symposium","volume":"2004","author":"Mendelson","year":"2001","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.mehy.2019.109501_b0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/pr.117.014381","article-title":"Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery","volume":"70","author":"Atkin","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mehy.2019.109501_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drugs abuse and dependence: an examination of reports to the European Medicines Agency (EMA) database of syuspected Adverse Drug Reactions (ADR)","author":"Schifano","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mehy.2019.109501_b0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pbb.2005.02.013","article-title":"The antinociceptive effect of zolpidem and zopiclone in mice","volume":"81","author":"Pick","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"10.1016\/j.mehy.2019.109501_b0065","article-title":"Antidepressants for insomnia in adults","author":"Everitt","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mehy.2019.109501_b0070","first-page":"27","article-title":"A controlled clinical study of a new antidepressant (Trazodone)","volume":"13","author":"De Gregorio","year":"1971","journal-title":"Panminerva Med"},{"key":"10.1016\/j.mehy.2019.109501_b0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00003495-198121060-00001","article-title":"Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety","volume":"21","author":"Brogden","year":"1981","journal-title":"Drugs"},{"key":"10.1016\/j.mehy.2019.109501_b0080","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr"},{"key":"10.1016\/j.mehy.2019.109501_b0085","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0028-3908(80)90197-5","article-title":"Biochemical investigations into the mode of action of trazodone","volume":"19","author":"Clements-Jewery","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2019.109501_b0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-4328(00)00185-6","article-title":"The antinociceptive effect of trazodone in mice is mediated through both m-opioid and serotonergic mechanisms","volume":"114","author":"Schreiber","year":"2000","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.mehy.2019.109501_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0924-977X(00)00069-9","article-title":"Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain","volume":"10","author":"Besson","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2019.109501_b0100","first-page":"19","article-title":"The pharmacologic profile of mirtazapine","volume":"57","author":"de Boer","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2019.109501_b0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0924-977X(97)00088-6","article-title":"Interaction between the tetracyclic antidepressant Mianserin HCl and opioid receptors","volume":"8","author":"Schreiber","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0110","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0361-9230(02)00825-0","article-title":"The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms","volume":"58","author":"Schreiber","year":"2002","journal-title":"Brain Res Bul"},{"key":"10.1016\/j.mehy.2019.109501_b0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0120","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/adb.12606","article-title":"The effects of the synthetic cannabinoid AB-FUBINACA on body temperature, nociceptive threshold, locomotor parameters and anxiety in mice","volume":"24","author":"Schreiber","year":"2019","journal-title":"Addict Biol"},{"key":"10.1016\/j.mehy.2019.109501_b0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0924-977X(96)00021-1","article-title":"Strain differences in mice antinociception: relationship between alprazolam and opioid receptor subtypes","volume":"6","author":"Pick","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0130","first-page":"24","article-title":"Tsc CKJ. Tricyclic antidepressants prescribing for non-psychiatric disorder. An analysis based on data from the National Ambulatory Medical Care Survey","volume":"33","author":"Broadhead","year":"1991","journal-title":"J Fam Pract"},{"key":"10.1016\/j.mehy.2019.109501_b0135","first-page":"88","article-title":"The use of fluoxetine for chronic pain management: a six weeks comparison study with amitriptyline","volume":"38","author":"Schreiber","year":"2001","journal-title":"ISR J Psychiatry Relat Sci"},{"key":"10.1016\/j.mehy.2019.109501_b0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ana.410130418","article-title":"Analgesic activity of tricyclic antidepressant","volume":"13","author":"Spiegel","year":"1983","journal-title":"Annu Neurol"},{"key":"10.1016\/j.mehy.2019.109501_b0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(90)90948-B","article-title":"The analgesic effect of tricyclic antidepressants","volume":"518","author":"Tura","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2019.109501_b0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410130209","article-title":"Amitriptyline potentiates morphine analgesia by direct action on the central nervous system","volume":"13","author":"Botney","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2019.109501_b0155","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0361-9230(88)90022-6","article-title":"Mediation of serotonin-induced analgesia by the 5-HT receptor in the pentobarbital anaesthetized mouse model","volume":"21","author":"Banks","year":"1988","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.mehy.2019.109501_b0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0091-3057(87)90548-X","article-title":"A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs","volume":"26","author":"Sacerdote","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.mehy.2019.109501_b0165","first-page":"368","article-title":"Blockade of acute opiate-withdrawal symptoms by trazodone treatment","volume":"118","author":"Fedeli","year":"1979","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.mehy.2019.109501_b0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.mehy.2019.109501_b0175","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/0269881110379307","article-title":"British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders","volume":"24","author":"Wilson","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0924-977X(96)00031-4","article-title":"The antinociceptive effect of fluvoxamine","volume":"6","author":"Schreiber","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0185","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.euroneuro.2005.11.013","article-title":"From selective to highly-selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram","volume":"16","author":"Schreiber","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0190","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.euroneuro.2009.06.004","article-title":"The antinociceptive properties of reboxetine in acute pain","volume":"19","author":"Schreiber","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2019.109501_b0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(98)00638-7","article-title":"The antinociceptive effect of moclobemide in mice is mediated by noradrenergic pathways","volume":"253","author":"Schreiber","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2019.109501_b0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(99)00627-8","article-title":"The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms","volume":"273","author":"Schreiber","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2019.109501_b0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0773.1994.tb00319.x","article-title":"Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation","volume":"75","author":"Wahlstr\u00f6m","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.mehy.2019.109501_b0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ageing\/afx167","article-title":"Z-drugs and risk for falls and fractures in older adults \u2013 a systematic review and meta-analysis","volume":"47","author":"Treves","year":"2018","journal-title":"Age Ageing"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719311235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719311235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:17:58Z","timestamp":1759691878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719311235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":42,"alternative-id":["S0306987719311235"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109501","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trazodone and mirtazapine: A possible opioid involvement in their use (at low dose) for sleep?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109501"}}